top of page

Stifel's Tim Opler discusses how the sector's recent rally is affecting things on the investment banking side

blonca9
2 hours ago
1 min read

He comments on IPOs, fundraising, M&A, and China.

Coverage brought to you by

ree

Recent Posts

Stifel's Head of Therapeutics Research Paul Matteis shares his take on the sector and discusses names he covers that have key catalyst events

Stifel's Head of Therapeutics Research Paul Matteis shares his take on the sector and discusses names he covers that have key catalyst events

Science Explainer: Brain shuttle technologies have been in the news a lot lately. Natalie Ricciardi explains what you need to know about 1st and 2nd generation technologies in development.

Science Explainer: Brain shuttle technologies have been in the news a lot lately. Natalie Ricciardi explains what you need to know about 1st and 2nd generation technologies in development.

Miami Oncology Summit: Medical Oncologist Dionysios Watson discusses the latest in lung and head & neck cancer, and his early stage research on next-gen immunotherapy

Miami Oncology Summit: Medical Oncologist Dionysios Watson discusses the latest in lung and head & neck cancer, and his early stage research on next-gen immunotherapy

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page